OncoLink at ASTRO 2001: Tuesday, November 6

Continuing OncoLink coverage from ASTRO 2001.

OncoLink at ASTRO 2001. Booth 2450.

A Phase II Trial of Subcutaneous Amifostine and Radiation Therapy in Patients with Head and Neck Cancer (WR-B060) Presenter: P. Anne Presenter's Affiliation: Radiation Oncology, Thomas Jefferson University Hospital, Philadelphia, PA Type of Session: Scientific Background Amifostine is an organic thiophosphate that protects normal tissues from the cytotoxic...
A Phase III Trial Comparing Whole-Pelvic (WP) to Prostate Only (PO) Radiotherapy and Neoadjuvant to Adjuvant Total Androgen Suppression (TAS): Preliminary Analysis of RTOG 9413 Presenter: M. Roach III Presenter's Affiliation: Radiation Oncology, UCSF, San Francisco, CA Type of Session: Plenary Background Many unanswered questions await definitive resolution in the treatment of prostate cancer. There has been significant...
A Prospective Study on Tumor Hypoxia Kinetics to Implement Hypoxic Imaging-Guided IMRT Presenter: Chao, KS Presenter's Affiliation: Radiology, Washington University, St. Louis, St. Louis, MO Type of Session: Scientific Background Unsatisfactory local/regional tumor control for locally advanced cancers with radiation therapy is in part...
Cost-Utility Analysis of RTOG 90-03: Phase III Randomized Study Comparing Altered Fractionation to Standard Fractionation Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma Presenter: A. Konski Presenter's Affiliation: Toledo Radiation Oncology, Hickman Cancer Center, Adrian, MI Type of Session: Scientific Background RTOG 90-03 a four-arm study that evaluated various fractionation schedules for the treatment of locally...
COX Inhibitors Markedly enhance Tumor Radiosensitization of Cultured Human Cancer Cells under Acidic Microenvironment Presenter: T.R. Shah Presenter's Affiliation: Henry Ford Hospital Type of Session: Scientific Background Prostaglandins are synthesized by COX enzymes. These prostaglandins have been implicated in carcinogenesis, angiogenesis, invasiveness, and...
Eight Year Results in the Treatment of Keloids by HDR Brachytherapy Presenter: B. Guix Presenter's Affiliation: Radiation Oncology, Fundacio IMOR, Barcelona, Spain Type of Session: Scientific Background Keloids form as a result of abnormal growth of scar tissue usually after injury to the skin. The incidence ranges...
Internet Utilization by Radiation Oncology Patients Presenter: J.M. Metz Presenter's Affiliation: Radiation Oncology, University of Pennsylvania, Philadelphia, PA Type of Session: Scientific Background Millions of people use the Internet daily. It is not unreasonable to postulate that many cancer...
Locoregional Failure of Post-Mastectomy Patients Who Had 1-3 Positive Axillary Lymph Nodes without Adjuvant Radiotherapy Presenter: C. Cheng Presenter's Affiliation: Sun Yat-Sen Cancer Center Type of Session: Scientific Background Post-mastectomy radiation is routinely given for patients with 4 or more positive lymph nodes to reduce locoregional failure. However,...
Molecular Markers of Patient Outcome in Prostate Cancer Treated with Radiotherapy: Ki-67, Bcl-2, Bax, and Bcl-x Presenter: A. Pollack Presenter's Affiliation: UT MD Anderson Cancer Center, Houston, TX Type of Session: Scientific Background Abnormal expression of certain proteins have been found to alter the normal process of dying, or apoptosis, in cells. To...
One Year Follow-up Reveals No Difference in Quality of Life Between High Dose and Conventional Dose Radiation: A Quality of Life Assessment of RTOG 94-05 Presenter: L.A. Kachnic Presenter's Affiliation: Radiation Therapy Oncology Group Type of Session: Scientific Background Nonsurgical standard of care for esophageal cancer is concurrent chemoradiation. A survival advantage has been demonstrated...
Patterns of Local Regional Failure in Head and Neck Cancer Treated with IMRT Presenter: Tran, BN Presenter's Affiliation: Mallinckrodt Institute of Radiology, Radiation Oncology Center, Washington University Medical Center, St. Louis, MO Type of Session: Scientific Background Intensity modulated radiation therapy allows...
PET Response is the Most Powerful Predictor of Survival after Radical Radiotherapy/Chemoradiotherapy for Unresectable Non-Small Cell Lung Cancer Presenter: M.P. MacManus Presenter's Affiliation: Peter MacCallum Cancer Institute, East Melbourne, Australia Type of Session: Scientific Background Frequently, clinicians have difficulty interpreting CT scans and MRI's done on patients with...
Positron Emission Tomography after Three-Dimensional Conformal Radiation Presenter: K.E. Rosenzweig Presenter's Affiliation: Memorial Sloan-Kettering Cancer Center, New York Type of Session: Scientific Background Frequently, clinicians have difficulty interpreting CT scans and MRI's done on patients with cancer,...
Preliminary Results of a Randomized Study of Tamoxifen Alone or Tamoxifen and Breast Radiation in Women over 50 Years of Age with T1/2 N0 Disease Presenter: A. Fyles Presenter's Affiliation: Princess Margaret Hospital Type of Session: Scientific Background The standard of care for women with invasive breast cancer who were treated with lumpectomy is adjuvant radiation therapy and tamoxifen...
Selenium in the Treatment of Radiation-Associated Lymphedemas Presenter: F. Bruns Presenter's Affiliation: Department of Radiotherapy and Radiation Oncology, University Hospital, Muenster, Germany Type of Session: Reporting Background : Lymphedema is a relatively common side effect after surgical and/or...
The Impact of Anemia on PSA Outcome following Radiation and Androgen Suppression Therapy in Patients with High-Risk Prostate Cancer Presenter: A.V. DAmico Presenter's Affiliation: Brigham and Women's Hospital, Boston, MA Type of Session: Scientific Background It is well known that in men testosterone has a permissive effect on hemeglobin (Hb)levels in the bone marrow and on...
Treatment of Acoustic Neuroma: Stereotactic Radiosurgery vs Microsurgery Presenter: Butler, EB Presenter's Affiliation: Baylor College of Medicine Type of Session: Scientific Background Two major treatment options are available for patients with acoustic neuroma, microsurgery and radiosurgery. The objective of this...